Cargando…

Inducing Immunity Where It Matters: Orthotopic HPV Tumor Models and Therapeutic Vaccinations

Anogenital and oropharyngeal cancers caused by human papillomavirus (HPV) infections account for 4.5% of all cancer cases worldwide. So far, only the initial infection with selected high-risk types can be prevented by prophylactic vaccination. Already existing persistent HPV infections, however, can...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zottnick, Samantha, Voß, Alessa L., Riemer, Angelika B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7457000/ https://www.ncbi.nlm.nih.gov/pubmed/32922389 http://dx.doi.org/10.3389/fimmu.2020.01750

Ejemplares similares

Development of an Orthotopic HPV16-Dependent Base of Tongue Tumor Model in MHC-Humanized Mice
por: Schifflers, Christoph, et al.
Publicado: (2023)

Effects of hypoxia on antigen presentation and T cell-based immune recognition of HPV16-transformed cells
por: Mohan, Nitya, et al.
Publicado: (2022)

Characterization of the early cellular immune response induced by HPV vaccines
por: Pasmans, Hella, et al.
Publicado: (2022)

The Combined Use of Melatonin and an Indoleamine 2,3-Dioxygenase-1 Inhibitor Enhances Vaccine-Induced Protective Cellular Immunity to HPV16-Associated Tumors
por: Moreno, Ana C. R., et al.
Publicado: (2018)

HPV16 E6/E7 -based mRNA vaccine is therapeutic in mice bearing aggressive HPV-positive lesions
por: Zhou, Kun, et al.
Publicado: (2023)

Postpartum HPV Vaccination Rate and Differences in Background Characteristics Between HPV Vaccinated and Unvaccinated Postpartum Women: Strict Monitoring and Follow-Up of Postpartum HPV Vaccination Program
por: Lee, Chung-Yuan, et al.
Publicado: (2021)

Modeling the tumor microenvironment of anaplastic thyroid cancer: an orthotopic tumor model in C57BL/6 mice
por: Xu, Zhen, et al.
Publicado: (2023)

Non-invasive Assessment of Vaccine-Induced HPV Antibodies via First-Void Urine
por: Pattyn, Jade, et al.
Publicado: (2020)

Editorial: Immunology of HPV Infection and Vaccination: Progress and Challenges
por: Licciardi, Paul V., et al.
Publicado: (2021)

Combination Therapy of Mithramycin A and Immune Checkpoint Inhibitor for the Treatment of Colorectal Cancer in an Orthotopic Murine Model
por: Dutta, Rinku, et al.
Publicado: (2021)

The Importance of Being Presented: Target Validation by Immunopeptidomics for Epitope-Specific Immunotherapies
por: Becker, Jonas P., et al.
Publicado: (2022)

A Potential Herbal Adjuvant Combined With a Peptide-Based Vaccine Acts Against HPV-Related Tumors Through Enhancing Effector and Memory T-Cell Immune Responses
por: Song, Ying-Chyi, et al.
Publicado: (2020)

The Where, When, How, and Why of Hyaluronan Binding by Immune Cells
por: Lee-Sayer, Sally S. M., et al.
Publicado: (2015)

Treatment with Imiquimod enhances antitumor immunity induced by therapeutic HPV DNA vaccination
por: Chuang, Chi-Mu, et al.
Publicado: (2010)

Next generation L2-based HPV vaccines cross-protect against cutaneous papillomavirus infection and tumor development
por: Ahmels, Melinda, et al.
Publicado: (2022)

Therapeutic Vaccination for HPV Induced Cervical Cancers
por: Brinkman, Joeli A., et al.
Publicado: (2007)

Therapeutic Vaccine Strategies against Human Papillomavirus
por: Khallouf, Hadeel, et al.
Publicado: (2014)

Immunotherapy of HPV-associated cancer: DNA/plant-derived vaccines and new orthotopic mouse models
por: Venuti, Aldo, et al.
Publicado: (2015)

Characterization of DoTc2 4510—Identifying HPV16 Presence in a Cervical Carcinoma Cell Line Previously Considered to Be HPV-Negative
por: Vučković, Nika, et al.
Publicado: (2023)

Enhanced Radiation Sensitivity of Human Papillomavirus-Driven Head and Neck Cancer: Focus on Immunological Aspects
por: Özcan-Wahlbrink, Mine, et al.
Publicado: (2019)

HPV Induces Changes in Innate Immune and Adhesion Molecule Markers in Cervical Mucosa With Potential Impact on HIV Infection
por: Britto, Alan Messala A., et al.
Publicado: (2020)

Photochemical Internalization Enhanced Vaccination Is Safe, and Gives Promising Cellular Immune Responses to an HPV Peptide-Based Vaccine in a Phase I Clinical Study in Healthy Volunteers
por: Otterhaug, Tone, et al.
Publicado: (2021)

Where Epigenetics Meets Food Intake: Their Interaction in the Development/Severity of Gout and Therapeutic Perspectives
por: Georgel, Philippe T., et al.
Publicado: (2021)

Discrepancies in the Tumor Microenvironment of Spontaneous and Orthotopic Murine Models of Pancreatic Cancer Uncover a New Immunostimulatory Phenotype for B Cells
por: Spear, Sarah, et al.
Publicado: (2019)

Tumor Burden and Immunotherapy: Impact on Immune Infiltration and Therapeutic Outcomes
por: Kim, Samuel I., et al.
Publicado: (2021)

Therapeutic Cancer Vaccine and Combinations With Antiangiogenic Therapies and Immune Checkpoint Blockade
por: Mougel, Alice, et al.
Publicado: (2019)

Combination of Ablation and Immunotherapy for Hepatocellular Carcinoma: Where We Are and Where to Go
por: Wang, Kunpeng, et al.
Publicado: (2021)

Innovative and Promising Strategies to Enhance Effectiveness of Immunotherapy for CNS Tumors: Where Are We?
por: Quintarelli, Concetta, et al.
Publicado: (2021)

Induction of Therapeutic Protection in an HPV16-Associated Mouse Tumor Model Through Targeting the Human Papillomavirus-16 E5 Protein to Dendritic Cells
por: Badillo-Godinez, Oscar, et al.
Publicado: (2021)

Immunity to Avian Leukosis Virus: Where Are We Now and What Should We Do?
por: Feng, Min, et al.
Publicado: (2016)

The Use of Immune Checkpoint Inhibitors in Oncology and the Occurrence of AKI: Where Do We Stand?
por: Franzin, Rossana, et al.
Publicado: (2020)

Editorial: Defects in Regulation: How, Where and When the Immune System Can Go Wrong
por: Rijkers, Ger T., et al.
Publicado: (2021)

Immunodiagnosis and Immunotherapeutics Based on Human Papillomavirus for HPV-Induced Cancers
por: Dong, Zhen, et al.
Publicado: (2021)

The Role of the Tumor Vasculature in the Host Immune Response: Implications for Therapeutic Strategies Targeting the Tumor Microenvironment
por: Hendry, Shona A., et al.
Publicado: (2016)

A humanized orthotopic mouse model for preclinical evaluation of immunotherapy in Ewing sarcoma
por: Luo, Wen, et al.
Publicado: (2023)

Therapeutic Antibodies: What Have We Learnt from Targeting CD20 and Where Are We Going?
por: Marshall, Michael J. E., et al.
Publicado: (2017)

Antigenic Peptide Prediction From E6 and E7 Oncoproteins of HPV Types 16 and 18 for Therapeutic Vaccine Design Using Immunoinformatics and MD Simulation Analysis
por: Jabbar, Basit, et al.
Publicado: (2018)

Control of HPV-associated tumors by innovative therapeutic HPV DNA vaccine in the absence of CD4+ T cells
por: Peng, Shiwen, et al.
Publicado: (2014)

Influence of Tumor Immune Infiltration on Immune Checkpoint Inhibitor Therapeutic Efficacy: A Computational Retrospective Study
por: Liu, Rong, et al.
Publicado: (2021)

Potent Neutralizing Humanized Antibody With Topical Therapeutic Potential Against HPV18-Related Cervical Cancer
por: Huang, Bilian, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_n4hl9obic1n3osouckdd4ce62g